International Journal of Radiation Oncology Biology Physics

Papers
(The H4-Index of International Journal of Radiation Oncology Biology Physics is 44. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
The R's of Radiation Therapy: Do We Need More or Do We Move On?184
If Medicine were my Spouse128
In Regard to Langé et al111
Mind Over Matter: Complete Craniospinal Irradiation or Just Treat the Spine104
Association of Inpatient Radiation Oncology Consult Timing with Length of Hospitalization and Opioid Utilization98
Effect of Postmastectomy Radiotherapy in Breast Cancer Patients according to Pathologic Nodal Status and Molecular Subtype after Neoadjuvant Chemotherapy90
Optimal Threshold of Smoking in Pack-Years and its Association with Survival Outcomes Among Patients Treated with Chemoradiation for Head and Neck Cancer89
Brachytherapy Capacity for Management of Cervical Cancer in Low- and Middle-Income Countries: An Updated IAEA Database Analysis84
Radiation Necrosis Risk in NSCLC Patients Receiving EGFR TKIs or ALK Inhibitors77
The LMP1/Lgals1-NF-Kb-IRF1-PDL1 Axis Promotes Immune Escape in Nasopharyngeal Carcinoma76
Breast Cancer Radiotherapy Experience in a Newly Established Cancer Center in Nigeria74
Dose-Escalated Ablative Radiotherapy as Definitive Treatment for Unresectable and Recurrent Intrahepatic Cholangiocarcinoma74
Salvage Ablative Radiation Therapy for Isolated Intraabdominal Recurrences of Hepatocellular Carcinoma74
Trends in Private Equity Involvement in Oncology Practices in the United States69
Risk of Diabetes Mellitus after Radiotherapy for Gastric Mucosa-Associated Lymphoid Tissue Lymphoma67
Hypofractionated vs. Conventionally Fractionated Radiotherapy for Glioblastoma: Peripheral Blood Leukocyte Comparison prior to and Following Chemoradiation66
In Silico Trial of Computed Tomography-Guided Stereotactic Adaptive Radiotherapy (CT-STAR) for the Treatment of Abdominal Oligometastases65
Clinically Consistent Prostate Cancer Outcome Prediction Models with Machine Learning63
Perineural Invasion Combined with Pattern C of the Silva Classification System Correlates Poor Prognosis in Cervical Adenocarcinoma Following a Radical Hysterectomy62
Prevalence and Functional Impact of Vertigo among Long Term Survivors of Head and Neck Cancer60
Does hippocampal atrophy correlate with patient-reported adaptive function one year following radiotherapy? Results from a prospective trial57
A National Cancer Disparities Analysis of Pacific Islanders Who Decline Radiation Therapy and Impacts on Overall Survival56
Novel Enhancement of Checkpoint Inhibition Using Pulsing Radiotherapy with Concurrent and Adjuvant CPI for LAHNSCC in Elderly Patients Considered Ineligible for Curative Intent Therapy56
Assessment of Nutritional and Imaging Biomarkers to Predict PEG Tube Placement in Non-HPV-Associated Head and Neck Patients Undergoing Concurrent Chemoradiotherapy56
Lymph Node Metastasis Spread Patterns and the Effectiveness of Prophylactic Neck Irradiation in Sinonasal Squamous Cell Carcinoma (SNSCC)54
Predictors of Interstitial Brachytherapy Utilization in Locally Advanced Cervical Cancer and Impact on Overall Survival53
Novel Bioprinted Pancreatic Tumor Model: A Translational Tool for Radiotherapy, Chemotherapy and Immunotherapy Efficacy Studies52
Overall Survival after Y-90 Selective Internal Radiotherapy of Liver Metastases in Oligometastatic Patients52
Systematic Implementation of Effective Quality Assurance Processes for the Assessment of Radiation Target Volumes in Head and Neck Cancer49
Clinical Outcomes in High Risk WHO Grade II Glioma Patients Treated with Upfront TMZ-Based Chemoradiotherapy49
Issue Highlights page48
Postoperative Radiotherapy can Improve the Disease-Free Survival of EGFR Wild Type Patients with pN2 NSCLC after Complete Resection and Adjuvant Chemotherapy48
The Maximum Standardized Uptake Value in Patients with Recurrent or Persistent Prostate Cancer after Radical Prostatectomy and PSMA-PET-Guided Salvage Radiotherapy – A Multicenter Retrospective Analys47
Withdrawn47
Effectiveness of Adjuvant Radiotherapy for High Recurrence Risk Patients with Upper Tract Urothelial Carcinoma47
Single Fraction HDR Brachytherapy for Prostate Cancer: SiFEPI Phase II Trial Results46
The Use of Breast Cup Immobilization in Radiation Therapy and Patient Reported Outcomes on Cosmesis and Pain46
NAUTIKA1: A Multicenter Phase II Study with a PD-L1+ Cohort of Patients Receiving Atezolizumab (Atezo) with Low-Dose Stereotactic Body Radiation Therapy (SBRT) as Neoadjuvant Therapy for Resectable St46
Stereotactic Arrhythmia Radioablation for Ventricular Tachycardia (StAR-VT): A Single Institution, Dose De-Escalation, Phase II Trial46
Outcomes Associated with the Use of Tissue Equivalent Bolus Tailored by Skin Involvement Status in Postmastectomy Radiotherapy: A Single-Blinded Randomized Clinical Trial45
Improving Interpretability of Machine Learning in Head and Neck Radiation Therapy Pretreatment Physics Plan Reviews45
Comparison of Diagnostic PET and 4D CT-Based Tumor Delineation for Oligometastatic Lung Tumors45
Withdrawn45
Disease-Free Survival of Patients with Muscle Invasive Bladder Cancer Treated by Radical Cystectomy vs. Bladder-Sparing Therapy at a Nationwide Level44
The Utility of Mean Apparent Diffusion Coefficient Value in Patients with Prostate Cancer Treated with Definitive Radiotherapy44
0.28511381149292